Valuation: Danaher Corporation

Market Cap 140B 123B 113B 105B 199B 13,363B 202B 1,353B 526B 6,559B 526B 515B 22,742B P/E 2026 *
31.5x
P/E 2027 * 26x
Enterprise Value 140B 123B 113B 105B 199B 13,363B 202B 1,353B 526B 6,559B 526B 515B 22,742B EV / Sales 2026 *
5.4x
EV / Sales 2027 * 4.96x
Free-Float
71.14%
Yield 2026 *
0.73%
Yield 2027 * 0.78%
1 day-2.18%
1 week+0.44%
Current month+1.65%
1 month+5.50%
3 months+0.78%
6 months-18.16%
Current year-15.42%
1 week 188.99
Extreme 188.99
198.23
1 month 174.22
Extreme 174.2162
198.23
Current year 160.93
Extreme 160.93
242.8
1 year 160.93
Extreme 160.93
242.8
3 years 160.93
Extreme 160.93
281.7
5 years 160.93
Extreme 160.93
333.96
10 years 75.71
Extreme 75.71
333.96
Manager TitleAgeSince
Chief Executive Officer 62 31/08/2020
Director of Finance/CFO - 27/02/2026
Chief Tech/Sci/R&D Officer - 24/08/2025
Director TitleAgeSince
Director/Board Member 74 30/06/1999
Chairman 74 31/12/1983
Director/Board Member 69 31/12/1983
Date Insider Type Main position Quantity % Market Cap.
05-14Free

Director

2,379 0.0003%
05-14Free

Director

2,379 0.0003%
05-14Free

Director

2,379 0.0003%
Change 5-day change 1-year change 3-year change Capi.($)
-2.18%+0.44%-3.01%-17.40% 140B
-1.12%+2.21%+23.62%+0.05% 195B
+1.60%+6.62%-19.05%+31.10% 151B
-1.20%+2.58%-57.05%-15.66% 67.09B
+0.86%+4.39%+24.11%+5.22% 54.34B
-0.26%+1.93%-25.36%-30.79% 44.63B
-0.11%+2.72%+9.28%+42.98% 37.24B
-0.07%-1.68%+9.52%+10.28% 36.91B
+4.18%+10.06%-14.82%+1.58% 30.24B
-1.11%-0.32%-13.09%-18.05% 29.82B
Average +0.06%+2.56%-6.59%+0.93% 78.58B
Weighted average by Cap. -0.42%+3.34%-3.17%+2.05%

Financials

2026 *2027 *
Net sales 25.96B 22.74B 20.94B 19.44B 36.92B 2,477B 37.42B 251B 97.57B 1,216B 97.5B 95.36B 4,215B 28.23B 24.72B 22.77B 21.13B 40.13B 2,692B 40.68B 273B 106B 1,322B 106B 104B 4,582B
Net income 4.42B 3.87B 3.56B 3.31B 6.28B 421B 6.36B 42.65B 16.6B 207B 16.59B 16.22B 717B 5.35B 4.68B 4.31B 4B 7.6B 510B 7.71B 51.64B 20.1B 250B 20.08B 19.64B 868B
Net Debt - -
Logo Danaher Corporation
Danaher Corporation is an industrial and technologic group organized around three families of products: - diagnostic equipment (40.5% of net sales); - life sciences equipment (29.8%); - biotechnology equipment (29.7%): ranging from basic biological research to the development and manufacturing of vaccines, biological drugs, cell and gene therapies, and new technologies such as mRNA. Net sales are distributed geographically as follows: the United States (40.6%), China (10.7%) and other (48.7%).
Employees
59,000
Date Price Change Volume
06/07/26 US$193.62 -2.18% 4,301,800
02/07/26 US$197.93 +2.17% 4,035,515
01/07/26 US$193.72 +1.70% 4,515,633
30/06/26 US$190.48 -1.19% 3,471,399
29/06/26 US$192.78 -1.74% 3,522,543
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
26
Last Close Price
197.93USD
Average target price
242.35USD
Spread / Average Target
+22.44%

Quarterly revenue - Rate of surprise